Ipsen Reorganizes Its US Neurology Platform and Confirms Its Goal to Become Profitable in the US in 2014

PARIS--(Healthcare Sales & Marketing Network)--Ipsen (Euronext: IPN; ADR: IPSEY) (IPN.PA) today announced that, as part of the accelerated execution of its strategy in the USA, the Group adopted a new organizational model for the distribution of Dysport&re... Biopharmaceuticals, NeurologyIpsen, Dysport
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news